The role of p21 in the progression of DCIS toward invasive carcinoma is not well understood although it is considered as a tumor inhibitor so long as other participants in the regulation of cell cycling, particularly p53, are functional [56]. Here, CDKN1A is linked to ductal breast carcinoma in situ.